Cel-Sci
CVM
#9815
Rank
S$60.31 M
Marketcap
S$7.55
Share price
-2.33%
Change (1 day)
-71.30%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -S$32.58 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$34.21 Million, an increase over its 2023 earnings that were of -S$39.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$32.58 Million-4.76%
2024 -S$34.21 Million-12.41%
2023 -S$39.06 Million-12.87%
2022 -S$44.83 Million-3.42%
2021 -S$46.42 Million13.44%
2020 -S$40.92 Million11.28%
2019 -S$36.77 Million179.81%
2018 -S$13.14 Million-48.72%
2017 -S$25.63 Million-16.23%
2016 -S$30.59 Million-23.63%
2015 -S$40.06 Million-5.47%
2014 -S$42.38 Million198.49%
2013 -S$14.2 Million
2010 -S$16.57 Million
2004 -S$5.6 Million12.38%
2003 -S$4.99 Million-16.59%
2002 -S$5.98 Million-59.28%
2001 -S$14.67 Million23.17%
2000 -S$11.91 Million20.12%
1999 -S$9.92 Million13.24%
1998 -S$8.76 Million-20%
1997 -S$10.95 Million46.55%
1996 -S$7.47 Million34.88%
1995 -S$5.54 Million2.38%
1994 -S$5.41 Million68%
1993 -S$3.22 Million78.57%
1992 -S$1.81 Million180%
1991 -S$0.65 Million25%
1990 -S$0.52 Million-0%
1989 -S$0.52 Million-71.43%
1988 -S$1.81 Million-0%
1987 -S$1.81 Million-46.15%
1986 -S$3.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-S$41.93 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-S$8.53 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.61 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-S$0.18 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.28 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
S$41.71 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.22 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA